オルソバイオロジクス市場-世界の産業規模、シェア、動向、機会、予測、製品別、用途別、エンドユーザー別、地域別、競合別、2020年～2030年

オルソバイオロジクスの世界市場は、2024年には58億9,000万米ドルと評価され、2030年までCAGR5.10%を記録しながら着実に成長すると予測されています。

骨、軟骨、腱、靭帯の治癒と再生を促進するために、成長因子、幹細胞、バイオマテリアルを含む生物学的材料を応用することを中心とするオルソバイオロジクスは、ヘルスケア産業の重要な拡大分野です。このような生物学的由来の治療は、整形外科、スポーツ医学、外傷治療において、身体の自然な修復メカニズムを強化するために広く用いられています。バイオテクノロジーの開発により、多血小板血漿（PRP）、骨移植片、合成代替品などの新しいオルソバイオロジクス的ソリューションの開発が加速しています。AAOSによる、オルソバイオロジクス分野における優れた研究に対する2025 Arnold I. Caplan Awardをはじめとする業界の評価は、この分野における技術革新の重要性を強調しています。低侵襲で再生可能な治療に対する需要が高まるにつれ、オルソバイオロジクス市場は一貫して世界の拡大が見込まれています。

主要な市場促進要因

人口の高齢化

主要な市場課題

長期データの不足

主要市場動向

幹細胞治療

目次

第1章 製品概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のオルソバイオロジクス市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別（関節内補充療法製品、脱灰骨マトリックス、合成オルソバイオロジクス製品、骨形成タンパク質、同種移植片など）
  • 用途別（変形性関節症、変形性関節症、脊椎固定術、軟部組織損傷など）
  • エンドユーザー別（病院、整形外科クリニック、外来診療センター、学術調査機関、歯科クリニック・施設）
  • 地域別（北米、欧州、アジア太平洋、南米、中東・アフリカ）
  • 企業別（2024年）
• 製品市場マップ
  • 製品別
  • 用途別
  • エンドユーザー別
  • 地域別

第6章 北米のオルソバイオロジクス市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のオルソバイオロジクス市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋のオルソバイオロジクス市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋：国別分析
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア

第9章 南米のオルソバイオロジクス市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのオルソバイオロジクス市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • アラブ首長国連邦
  • サウジアラビア
  • 南アフリカ

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収
• 製品開発
• 最近の動向

第13章 ポーター分析

第14章 PESTEL分析

第15章 競合情勢

• Sanofi SA
• Stryker Corporation
• Zimmer Biomet
• Seaspine Holdings Corporation
• Medtronic PLC
• DePuy Synthes
• Bioventrus
• Globus Medical
• Arthrex Limited
• Orthofix International

第16章 戦略的提言

第17章 調査会社について・免責事項

The Global Orthobiologics Market was valued at USD 5.89 billion in 2024 and is projected to grow steadily, registering a CAGR of 5.10% through 2030. Orthobiologics represent a vital and expanding area of the healthcare industry, centered on the application of biological materials-including growth factors, stem cells, and biomaterials-to facilitate the healing and regeneration of bones, cartilage, tendons, and ligaments. These biologically derived treatments are widely used in orthopedic surgery, sports medicine, and trauma care to enhance the body's natural repair mechanisms. Advances in biotechnology have accelerated the development of novel orthobiologic solutions such as platelet-rich plasma (PRP), bone grafts, and synthetic alternatives. Industry recognition, including the 2025 Arnold I. Caplan Award for Distinguished Research in Orthobiologics by AAOS, emphasizes the significance of innovation in this space. As demand rises for minimally invasive and regenerative treatments, the orthobiologics market is positioned for consistent global expansion.

Key Market Drivers

Aging Population

The aging global population is a key contributor to the rising demand in the orthobiologics market. With population forecasts by the World Population Prospects 2024 projecting a peak of 10.3 billion by the mid-2080s, the proportion of elderly individuals is set to rise significantly. Aging individuals are increasingly affected by musculoskeletal conditions such as osteoarthritis, joint degeneration, and fractures. These ailments drive demand for less invasive and regenerative treatments, with orthobiologic products like PRP and stem cell therapies emerging as preferred options. Older patients often seek therapeutic solutions that can relieve pain, promote tissue healing, and improve mobility without undergoing major surgery, fueling the market's growth trajectory.

Key Market Challenges

Lack of Long-Term Data

A major limitation in the orthobiologics space is the scarcity of long-term clinical data regarding the safety and efficacy of these treatments. While short-term outcomes have been promising, there is limited evidence on the durability of results, the need for retreatment, and potential long-term complications. This lack of comprehensive follow-up data can cause hesitation among clinicians and patients, slowing widespread adoption. Additionally, the absence of standardized treatment protocols restricts integration into routine clinical practice. Greater investment in long-term studies, post-market surveillance, and real-world evidence is essential to strengthen clinical confidence and support regulatory decision-making.

Key Market Trends

Stem Cell Therapies

Stem cell therapies are gaining traction as a transformative trend in orthobiologics, offering innovative regenerative options for orthopedic care. These therapies utilize either autologous or allogeneic stem cells to restore damaged musculoskeletal tissues. Applications include treatment for osteoarthritis, bone injuries, and cartilage defects. Autologous treatments like bone marrow aspirate concentrate (BMAC) and adipose-derived stem cells capitalize on the body's innate healing ability, while allogeneic options provide ready-to-use therapeutic alternatives. As biotechnology advances, enhanced techniques in cell processing and culture are driving the precision and effectiveness of these treatments. Despite the promise, regulatory challenges and the need for long-term clinical validation remain central to the responsible integration of stem cell-based therapies in mainstream orthopedic care.

Key Market Players

• Sanofi SA
• Stryker Corporation
• Zimmer Biomet
• Seaspine Holdings Corporation
• Medtronic PLC
• DePuy Synthes
• Bioventrus
• Globus Medical
• Arthrex Limited
• Orthofix International

Report Scope:

In this report, the Global Orthobiologics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Orthobiologics Market, By Product:

• Viscosupplementation Products
• Demineralized Bone Matrices
• Synthetic Orthobiologics
• Bone Morphogenic Protein
• Allografts
• Others

Orthobiologics Market, By Application:

• Osteoarthritis and Degenerative Arthritis
• Spinal Fusion
• Soft-tissue Injuries
• Others

Orthobiologics Market, By End User:

• Hospitals
• Orthopedic Clinics
• Ambulatory Care Centers
• Academic and Research Institutes
• Dental Clinics and Facilities

Orthobiologics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Orthobiologics Market.

Available Customizations:

Global Orthobiologics Market report with the given Market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional Market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Types
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Orthobiologics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Viscosupplementation Products, Demineralized Bone Matrices, Synthetic Orthobiologics, Bone Morphogenic Protein, Allografts, and Others)
  • 5.2.2. By Application (Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Soft-tissue Injuries, and Others)
  • 5.2.3. By End User (Hospitals, Orthopedic Clinics, and Ambulatory Care Centers, Academic and Research Institutes, and Dental Clinics and Facilities)
  • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.5. By Company (2024)
• 5.3. Product Market Map
  • 5.3.1. By Product
  • 5.3.2. By Application
  • 5.3.3. By End User
  • 5.3.4. By Region

6. North America Orthobiologics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Orthobiologics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Orthobiologics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Orthobiologics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Orthobiologics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Orthobiologics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. France Orthobiologics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Orthobiologics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Orthobiologics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Orthobiologics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
    • 7.3.5.3. By Product
    • 7.3.5.4. By Application
    • 7.3.5.5. By End User

8. Asia-Pacific Orthobiologics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Orthobiologics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. Japan Orthobiologics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. India Orthobiologics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Orthobiologics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Orthobiologics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Orthobiologics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Orthobiologics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Orthobiologics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Orthobiologics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Orthobiologics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. UAE Orthobiologics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Orthobiologics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. South Africa Orthobiologics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition
• 12.2. Product Development
• 12.3. Recent Developments

13. Porter's analysis

14. PESTEL analysis

15. Competitive Landscape

• 15.1. Sanofi SA
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
• 15.2. Stryker Corporation
• 15.3. Zimmer Biomet
• 15.4. Seaspine Holdings Corporation
• 15.5. Medtronic PLC
• 15.6. DePuy Synthes
• 15.7. Bioventrus
• 15.8. Globus Medical
• 15.9. Arthrex Limited
• 15.10. Orthofix International

16. Strategic Recommendations

17. About Us & Disclaimer